Endo to Pull Opana From the Market Following FDA Request (via Pharmacy Times)
By: Jennifer Barrett, Assistant Editor, Pharmacy Times Endo International has announced its plan to withdraw Opana ER (oxymorphone hydrochloride extended release) from the market, following the FDA’s request to remove the reformulated opioid pain medication in June. Opana ER was first approved in 2006 for the management of pain severe enough to require daily, around-the-clock, long-term opioid […]
Newest Drug Approvals
The FDA has recently approved the following medications: Brineura from BioMarin was approved in April for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2). This fatal genetic neurodegenerative disease affects 1 in 12,500 live births and Brineura is specifically indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years […]
Dehydration and Kidney Stones
During the summer months the heat is turned up and your chance of becoming dehydrated is increased. One of the possible side effects of dehydration is the development of kidney stones. When urine is too concentrated from lack of fluids, minerals can build up and form stones. Stones vary in size from tiny crystals that […]
Cataract Awareness Month
Does it feel like when you look at things, they aren’t as crisp, clear or colorful as they used to be? Do things look cloudy or blurry even when you’re wearing glasses? These could be symptoms of cataracts. Cataracts is one of the leading causes of vision loss in the US and the primary cause […]
What you should know about Testicular Cancer
It’s rare, but it does happen. A man’s chance of getting testicular cancer is about 1 in 263 which translates to a about 20,000 men every year. Testicular cancer is rare, accounting for about 1% of all male cancers. However,testicular cancer is the most common form of cancer in men ages 15-35. The good news […]